RHOSTATIN



Trademark Coverage

No Class Specified

Pharmaceuticals, namely therapeutic drugs administered in the treatment of cancer

Owner

BioAxone Therapeutique Inc.

Business in Montreal, Quebec, CA

Owns 3 trademarks

Timeline
  • Dec 27
    2013
    Cancelled SEC 8 (6 Yr)
  • May 22
    2007
    Registered Principal Register
  • Mar 08
    2007
    Review Of Correspondence Complete
  • Mar 06
    2007
    Published For Opposition
  • Feb 14
    2007
    Notice Of Publication
  • Feb 02
    2007
    Paper Received
  • Jan 18
    2007
    Law Office Publication Review Completed
  • Jan 16
    2007
    Approved For PUB Principal Register
  • Jan 11
    2007
    Examiner's Amendment Entered
  • Jan 11
    2007
    Examiners Amendment Mailed
  • Jan 11
    2007
    Examiners Amendment Written
  • Jan 05
    2007
    Amendment From Applicant Entered
  • Dec 01
    2006
    Correspondence Received In Law Office
  • Jan 05
    2007
    Assigned To LIE
  • Dec 01
    2006
    Paper Received
  • Oct 11
    2006
    Inquiry As To Suspension Mailed
  • Oct 10
    2006
    Suspension Inquiry Written
  • Sep 14
    2006
    LIE Checked SUSP To ATTY For Action
  • Mar 16
    2006
    Applicant/Correspondence Changes (Non Responsive) Entered
  • Feb 07
    2006
    Paper Received
  • Feb 16
    2006
    Report Completed Suspension Check Case Still Suspended
  • Jun 15
    2005
    Letter Of Suspension Mailed
  • Jun 14
    2005
    Suspension Letter Written
  • Jun 10
    2005
    Amendment From Applicant Entered
  • May 05
    2005
    Correspondence Received In Law Office
  • May 05
    2005
    Paper Received
  • Jan 04
    2005
    Inquiry As To Suspension Mailed
  • Jan 03
    2005
    Suspension Inquiry Written
  • Dec 08
    2004
    LIE Checked SUSP To ATTY For Action
  • May 24
    2004
    Letter Of Suspension Mailed
  • May 03
    2004
    Correspondence Received In Law Office
  • May 03
    2004
    Paper Received
  • Mar 23
    2004
    Inquiry As To Suspension Mailed
  • Aug 05
    2003
    Letter Of Suspension Mailed
  • Jul 31
    2003
    Assigned To Examiner